1017 related articles for article (PubMed ID: 19853437)
41. Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Steward WP; Verweij J; Somers R; Spooner D; Kerbrat P; Clavel M; Crowther D; Rouesse J; Tursz T; Tueni E
J Clin Oncol; 1993 Jan; 11(1):15-21. PubMed ID: 8418226
[TBL] [Abstract][Full Text] [Related]
42. High-dose ifosfamide in the treatment of sarcomas of soft tissues and bone.
Demetri GD
Semin Oncol; 1996 Jun; 23(3 Suppl 6):22-6. PubMed ID: 8677444
[TBL] [Abstract][Full Text] [Related]
43. The role of ifosfamide in the treatment of sarcomas.
Dirix LY; Van Oosterom AT
Semin Oncol; 1989 Feb; 16(1 Suppl 3):39-45. PubMed ID: 2649984
[TBL] [Abstract][Full Text] [Related]
44. Phase II trial of ifosfamide in combination with the VEGFR inhibitor sorafenib in advanced soft tissue sarcoma: a Spanish group for research on sarcomas (GEIS) study.
García Del Muro X; Maurel J; Martínez Trufero J; Lavernia J; López Pousa A; de Las Peñas R; Cubedo R; Berros JP; Casado Herráez A; de Juan A; Martín Broto J
Invest New Drugs; 2018 Jun; 36(3):468-475. PubMed ID: 29527631
[TBL] [Abstract][Full Text] [Related]
45. Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial.
Filleron T; Le Guellec S; Chevreau C; Cabarrou B; Lesluyes T; Lodin S; Massoubre A; Mounier M; Poublanc M; Chibon F; Valentin T
BMC Cancer; 2020 Jul; 20(1):716. PubMed ID: 32736540
[TBL] [Abstract][Full Text] [Related]
46. High-dose ifosfamide in the treatment of advanced soft tissue sarcomas.
Tursz T
Semin Oncol; 1996 Jun; 23(3 Suppl 7):34-9. PubMed ID: 8711500
[TBL] [Abstract][Full Text] [Related]
47. First-line treatment of metastatic or locally advanced unresectable soft tissue sarcomas with conatumumab in combination with doxorubicin or doxorubicin alone: a phase I/II open-label and double-blind study.
Demetri GD; Le Cesne A; Chawla SP; Brodowicz T; Maki RG; Bach BA; Smethurst DP; Bray S; Hei YJ; Blay JY
Eur J Cancer; 2012 Mar; 48(4):547-63. PubMed ID: 22240283
[TBL] [Abstract][Full Text] [Related]
48. Experience with ifosfamide in the EORTC Soft Tissue and Bone Sarcoma Group.
Blackledge G; Steward WP; Verweij J; Mouridsen H; Bramwell V; Schütte J; van Oosterom A; Dombernowsky P; Buesa J; Van Glabekke M
Semin Oncol; 1992 Feb; 19(1 Suppl 1):14-8. PubMed ID: 1411615
[TBL] [Abstract][Full Text] [Related]
49. Alternating sequential chemotherapy with high-dose ifosfamide and doxorubicin/cyclophosphamide for adult non-small round cell soft tissue sarcomas.
Kawai A; Umeda T; Wada T; Ihara K; Isu K; Abe S; Ishii T; Sugiura H; Araki N; Ozaki T; Yabe H; Hasegawa T; Tsugane S; Beppu Y;
J Orthop Sci; 2005 May; 10(3):258-63. PubMed ID: 15928887
[TBL] [Abstract][Full Text] [Related]
50. The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial.
Pasquali S; Pizzamiglio S; Touati N; Litiere S; Marreaud S; Kasper B; Gelderblom H; Stacchiotti S; Judson I; Dei Tos AP; Verderio P; Casali PG; Woll PJ; Gronchi A;
Eur J Cancer; 2019 Mar; 109():51-60. PubMed ID: 30690293
[TBL] [Abstract][Full Text] [Related]
51. Phase I/II study of docetaxel, ifosfamide, and doxorubicin in advanced, recurrent, or metastatic soft tissue sarcoma (STS).
Suppiah R; Wood L; Elson P; Budd GT
Invest New Drugs; 2006 Nov; 24(6):509-14. PubMed ID: 16791410
[TBL] [Abstract][Full Text] [Related]
52. Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy.
Barişta I; Tekuzman G; Yalçin S; Güllü I; Güler N; Ozişik Y; Kars A; Celik I; Türker A; Altundağ K; Zengin N; Uner A; Baltali E; Firat D
J Surg Oncol; 2000 Jan; 73(1):12-6. PubMed ID: 10649272
[TBL] [Abstract][Full Text] [Related]
53. Isolated limb perfusion with cisplatin and doxorubicin for locally advanced soft tissue sarcoma of an extremity.
Eroglu A; Kocaoglu H; Demirci S; Akgül H
Eur J Surg Oncol; 2000 Apr; 26(3):213-21. PubMed ID: 10753532
[TBL] [Abstract][Full Text] [Related]
54. Metastatic soft tissue sarcoma chemotherapy: an opportunity for personalized medicine.
Reed D; Altiok S
Cancer Control; 2011 Jul; 18(3):188-95. PubMed ID: 21666581
[TBL] [Abstract][Full Text] [Related]
55. A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas.
Bokemeyer C; Franzke A; Hartmann JT; Schöber C; Arseniev L; Metzner B; Link H; Kanz L; Schmoll HJ
Cancer; 1997 Oct; 80(7):1221-7. PubMed ID: 9317171
[TBL] [Abstract][Full Text] [Related]
56. Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas.
Nielsen OS; Reichardt P; Christensen TB; Pink D; Daugaard S; Hermans C; Marreaud S; van Glabbeke M; Blay J; Judson I
Eur J Cancer; 2006 Sep; 42(14):2303-9. PubMed ID: 16891112
[TBL] [Abstract][Full Text] [Related]
57. Chemotherapy of soft tissue sarcoma--a clinical evaluation of treatment over ten years.
Wall N; Starkhammar H
Acta Oncol; 2003; 42(1):55-61. PubMed ID: 12665332
[TBL] [Abstract][Full Text] [Related]
58. Doxorubicin plus ifosfamide with rhGM-CSF in the treatment of advanced adult soft-tissue sarcomas: preliminary results of a phase II study from the EORTC Soft-Tissue and Bone Sarcoma Group.
Steward WP; Verweij J; Somers R; Blackledge G; Clavel M; Van Oosterom AT; Greifenberg B; Soedirman J; Thomas D; Van Glabbeke M
J Cancer Res Clin Oncol; 1991; 117 Suppl 4():S193-7. PubMed ID: 1795008
[TBL] [Abstract][Full Text] [Related]
59. Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic.
Demetri GD; Elias AD
Hematol Oncol Clin North Am; 1995 Aug; 9(4):765-85. PubMed ID: 7490240
[TBL] [Abstract][Full Text] [Related]
60. Low dose adriamycin and ifosfamide in the treatment of advanced adult soft tissue sarcomas.
Comandone A; Bretti S; Bertetto O; Oliva C; Bergnolo P; Bumma C
Anticancer Res; 2000; 20(3B):2077-80. PubMed ID: 10928155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
